All News

What to look for this week on Contemporary OB/GYN®

Trust is down in hospitals and the health system as a whole.\

Here's what you missed this week.

The company has publicized data from the TeenCOVE study of the vaccine along with plans to seek authorization in the coming weeks.

The human papillomavirus (HPV) vaccine is a key intervention for a number of cancers, but the opportunity to discuss the vaccine is missed all too often. Could an online educational program help clinicians improve their HPV vaccine communication strategies?

Despite the increase in availability, many patients still don’t know whether their physicians offer telehealth.

You can expect a variety of topics to be covered this week on Contemporary OB/GYN®, including:

A survey found that the pandemic boosted physician burnout and woke many up to their financial precarity.

A study examined the difference in prescribing patterns between pediatricians and dermatologists when it came to acne treatments.

A recently updated Practice Advisory from the American College of Obstetricians and Gynecologists (ACOG) provides an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.

Introducing Contemporary OB/GYN® Editorial Advisory Board member, Laura E. Riley, MD.

The tool becomes available as Good Neighbor Pharmacy surpasses 1 million doses allocated through its Federal Retail Pharmacy Program partnership to independent pharmacies nationwide.

New findings support current guidelines to avoid pregnancy for 12 to 24 months after bariatric surgery, adding emphasis on achieving gestational weight gain.

Shared decision-making (SDM) and patient decision aids (PtDAs) can lower health care costs, lower utilization, and increase prevention-related care; however, these outcomes are not always guaranteed, according to the results of a recent study presented during the 2021 Pharmacy Quality Alliance Annual Meeting.

Host Scott Kober discusses the impact of sexually transmitted infections (STIs) on women’s fertility with experts Jenell Coleman Fennell, MD, MPH, and Molly Quinn, MD.

Oral contraceptive pills (OCPs) and progestogens are effective treatment in two-thirds of women with symptomatic endometriosis, according to a review in the Journal of Clinical Medicine.

A new study, which was published in JAMA, investigated the immunogenicity in 103 pregnant and lactating individuals aged 18 to 45 years who received either the Pfizer of Moderna COVID-19 vaccines.

The new analysis, which was presented virtually at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting, concludes that the TDS maintained similar safety and tolerability in the 2 groups of women.

Fibroid uterus cases with anemia in premenopausal women are more likely to have vitamin D deficiency as compared to cases without anemia, according to a study from India in the journal Cureus.

A systematic review of the effectiveness of dietary interventions to treat endometriosis in the journal Reproductive Sciences has found a potential benefit of the Mediterranean diet and antioxidant supplementation on endometriosis-associated pain.

Nearly a third of women in poor or fair health have been without health care during the COVID-19 pandemic. Even more worrisome, only half of uninsured women have been to an ob/gyn provider over the past 3 years.

A Quest Diagnostics 2020 retrospective, longitudinal Health Trends Study® adds to previous research that shows co-testing is more effective than single testing alone.

Laura E. Riley, MD gives advice to residents, and practitioners just beginning their careers, on maintaining a healthy lifestyle while balancing the demands of the workplace. She is joined by Contemporary OB/GYN®’s Associate Editor, Lindsey Carr.

Contrary to popular belief, emergency oral contraception is not that effective.

Eligible children and teens should receive COVID-19 vaccination to protect them from COVID-19 infection, as well as to reduce the spread of the virus in the community and to vulnerable people, according to the statement.

A prospective study has concluded that women of childbearing age with uterine fibroids (UF) who desire to preserve fertility benefit from the combined oral supplementation of vitamin D, epigallocatechin gallate (EGCG) and vitamin B6.

The most significant finding is to watch for symptoms of VVC in women with T2D.

What to look for this week on Contemporary OB/GYN®